Vaccine CDMOs are helping pharmaceutical companies to roll out their inoculation doses on a vast scale. However, this is resulting in ecological and sustainability considerations that must be addressed. These considerations could cause problems for humanity and our planet in the future.
When the outlook appeared bleak during the worst of the COVID-19 pandemic, vaccine manufacturers stepped up and performed admirably, delivering inoculations on a vast scale. Now, equipment solutions such as vial filling machines are helping manufacturers remain sustainable and eco-friendly.
The development of vaccines is accelerating rapidly, and vaccine CDMOs and other contract pharmaceutical manufacturers are supporting this. The contributions these CDMOs make at various points along the vaccine development and supply chain cannot be overstated.
A CDMO is a contract development and manufacturing organization contracted to complete key tasks in the development, production and distribution chain. These companies are crucial in the fight against Covid-19, and vaccine CDMOs are driving the recovery phase of the global pandemic.
Equipment and technology are at the forefront of the fight against COVID-19, and this is still the case as vaccines are rolled out to the public. From vaccine trays and ready-to-use sterile vials to more sophisticated tech like ultracentrifuges, equipment solutions are proving crucial.
Solutions such as vial trays and vaccine trays are crucial to successful pharmaceutical manufacturing, but how are these containers filled and prepared for distribution? This is where fill/finish comes into play — a process that bridges the gap between pharma production and deployment in the field.